Martina Svenja Lutz

6PUBLICATIONS
4CO-AUTHORS
Tumour immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma.

|Feb 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein

|Jan 22, 2026
Targeting NKG2DLs with an ADCC enhanced fusion protein for induction of NK cell reactivity against ovarian cancer.

Ilona Hagelstein, Kevin Wang, Annika Hölz

|Jul 16, 2025
Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer Treatment.

Ilona Hagelstein, Sven Mattern, Kevin Wang

|Oct 04, 2024
Targeting CD276 for T cell-based immunotherapy of breast cancer.

Ilona Hagelstein, Laura Wessling, Alexander Rochwarger

|Feb 03, 2022
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies.

Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer

Pageof 1

Frequent Collaborators

1 joint publications

Yannick E Haueisen

1 joint publications

Sylwia A Stefańczyk

1 joint publications

Samuel J Holzmayer

1 joint publications

Melanie Märklin